LeConte Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.35M Buy
5,085
+12
+0.2% +$3.17K 0.72% 33
2026
Q2
$1.29M Buy
5,073
+207
+4% +$48.2K 0.7% 30
2026
Q1
$1.19M Buy
4,866
+104
+2% +$24.2K 0.77% 28
2025
Q4
$986K Buy
4,762
+355
+8% +$70.2K 0.64% 27
2025
Q3
$817K Buy
4,407
+852
+24% +$146K 0.55% 29
2025
Q2
$543K Buy
3,555
+737
+26% +$113K 0.37% 39
2025
Q1
$467K Buy
+2,818
New +$441K 0.3% 30

Other funds holding JNJ

LeConte Wealth Management's JNJ Position: Q3 2026 in Review

LeConte Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.24% in Q3 2026, buying an estimated $3.17K and bringing the position to 5,085 shares worth $1.35M. The position accounts for 0.72% of the portfolio, ranked #33.

LeConte Wealth Management first reported a position in JNJ in Q1 2025 and has held it in 7 quarters since. 1,735 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • LeConte Wealth Management held 5,085 shares of Johnson & Johnson worth $1.35M as of Q3 2026.
  • LeConte Wealth Management bought 12 Johnson & Johnson shares in Q3 2026, an estimated $3.17K.
  • Johnson & Johnson made up 0.72% of LeConte Wealth Management's portfolio in Q3 2026, its #33 holding.
  • LeConte Wealth Management first reported a position in Johnson & Johnson in Q1 2025 and has held it in 7 quarters since.
  • 1,735 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.